Siby P. Moonnumakal, MD

Personal Statement

Dr. Moonnumakal believes in spending time with each family to listen to their concerns, educate them about their children’s respiratory problems, and then work together to customize a care plan.  He cares for most general pulmonary diseases but has special interest in asthma, cystic fibrosis, and medical education.  He is a native Houstonian that is bilingual and takes great pride in serving the families and children of the area.  Dr. Moonnumakal leads the Pulmonary Medicine section at the Texas Children’s Hospital West Campus location near Katy.  The team emphasizes providing the same quality of care provided by the nationally ranked Pulmonary section in a more convenient setting for patients in the area. 

Education

,

,

Organizations

,

,

* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.  Muhlebach MS, Beckett V, Popowitch E, Miller MB, Baines A, Mayer-Hamblett N, Zemanick ET, Hoover WC, VanDalfsen JM, Campbell P, Goss CH; STAR-too study team.Thorax. 2017 Apr;72(4):318-326. doi: 10.1136/thoraxjnl-2016-208949. Epub 2016 Nov 15.PMID: 27852955.

Evaluation of Vancomycin Dosing in Pediatric Cystic Fibrosis Patients.  McDade EJ, Hewlett JL, Moonnumakal SP, Baker CJ. J Pediatr Pharmacol Ther. 2016 Mar-Apr;21(2):155-61. doi: 10.5863/1551-6776-21.2.155.PMID: 27199623.

Characterization of a recurrent 3.8kb deletion involving exons 17a and 17b within the CFTR gene.  Tang S, Moonnumakal SP, Stevens B, Douglas G, Mason S, Schmitt ES, Eng CM, Katz M, Fang P. J Cyst Fibros. 2013 May;12(3):290-4. doi: 10.1016/j.jcf.2012.08.017. Epub 2012 Sep 19.PMID: 22998936.